Clinical Trial Update: Azithromycin in the Treatment of M. Avium Complex Lung Disease [Phase 4]

View source ↗

Summary

Phase 4 trial of azithromycin for Mycobacterium avium complex lung disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Lung Disease

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: The University of Texas Health Science Center at Tyler | Conditions: Mycobacterium Avium Complex Lung Disease | Phase 4 | Status: COMPLETED